Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of August 2026

  1. Biohaven Pharmaceutical Holding Company

    World Rank (Aug-2026)
    6,000
    Market Cap (Aug-2026)
    2.211 Billion USD
    World Rank (Jan-05-2024)
    3,972
    Market Cap (Jan-05-2024)
    3.399 Billion USD
    World Rank (Jul-30-2023)
    7,470
    Market Cap (Jul-30-2023)
    1.300 Billion USD
    World Rank (Dec-25-2022)
    8,706
    Market Cap (Dec-25-2022)
    0.934 Billion USD
    World Rank (Jan-07-2022)
    2,147
    Market Cap (Jan-07-2022)
    8.44 Billion USD
    Annual Revenue in USD
    463 Million USD
    Annual Operating Income in USD
    -704 Million USD
    Annual Net Income in USD
    -847 Million USD
    Annual Results for Period Ending
    For year ending December-2021
    Headquarters Country
    USA
    Yahoo @ NYSE
    Company Profile

    Biohaven Pharmaceutical Holding Company is a Clinical Stage Biopharmaceutical company. It portfolio is comprised of innovative, late stage product candidates targeting neurological and neuropsychiatric diseases including rare disorders. The company is rapidly progressing multiple compounds in clinical trials across three platforms they are calcitonin gene related peptide receptor antagonism, glutamate modulation and myeloperoxidase inhibition. The headquarters is in USA.

    Company Website
    BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.

  2. Ocular Therapeutix

    World Rank (Aug-2026)
    6,015
    Market Cap (Aug-2026)
    2.205 Billion USD
    World Rank (Jan-05-2024)
    12,314
    Market Cap (Jan-05-2024)
    0.523 Billion USD
    World Rank (Jul-30-2023)
    14,969
    Market Cap (Jul-30-2023)
    0.350 Billion USD
    World Rank (Dec-25-2022)
    17,875
    Market Cap (Dec-25-2022)
    0.206 Billion USD
    World Rank (Jan-07-2022)
    13,549
    Market Cap (Jan-07-2022)
    0.49 Billion USD
    Annual Revenue in USD
    52 Million USD
    Annual Operating Income in USD
    -270 Million USD
    Annual Net Income in USD
    -266 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Ocular Therapeutix is a Biopharmaceutical Platform company focused on the formulation, development and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel based formulation technology. The company annual revenue is 12.3 million USD and 167 employees as on 2019. The headquarters is in USA.
    Company Website
    OCULAR THERAPEUTIX

  3. Nuvation Bio Inc.

    World Rank (Aug-2026)
    6,043
    Market Cap (Aug-2026)
    2.184 Billion USD
    World Rank (Jan-05-2024)
    15,248
    Market Cap (Jan-05-2024)
    0.327 Billion USD
    World Rank (Jul-30-2023)
    14,372
    Market Cap (Jul-30-2023)
    0.385 Billion USD
    World Rank (Dec-25-2022)
    14,104
    Market Cap (Dec-25-2022)
    0.387 Billion USD
    World Rank (Jan-07-2022)
    7,508
    Market Cap (Jan-07-2022)
    1.47 Billion USD
    Annual Revenue in USD
    63 Million USD
    Annual Operating Income in USD
    -213 Million USD
    Annual Net Income in USD
    -205 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Profile

    Nuvation Bio is a Biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. The headquarters is in USA.

    Company Website
    NUVATION BIO INC.

  4. Precigen Inc.

    World Rank (Aug-2026)
    6,044
    Market Cap (Aug-2026)
    2.184 Billion USD
    World Rank (Jan-05-2024)
    15,259
    Market Cap (Jan-05-2024)
    0.326 Billion USD
    World Rank (Jul-30-2023)
    15,121
    Market Cap (Jul-30-2023)
    0.341 Billion USD
    World Rank (Dec-25-2022)
    15,801
    Market Cap (Dec-25-2022)
    0.296 Billion USD
    World Rank (Jan-07-2022)
    11,639
    Market Cap (Jan-07-2022)
    0.67 Billion USD
    Annual Revenue in USD
    10 Million USD
    Annual Operating Income in USD
    -111 Million USD
    Annual Net Income in USD
    -251 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Profile
    Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in immuno-oncology, autoimmune disorders and infectious diseases. The company annual revenue is 103 million USD as on 2020. The headquarters is in USA.
    Company Website
    PRECIGEN, INC.

  5. Aurinia Pharmaceuticals

    World Rank (Aug-2026)
    6,240
    Market Cap (Aug-2026)
    2.058 Billion USD
    World Rank (Jan-05-2024)
    7,666
    Market Cap (Jan-05-2024)
    1.213 Billion USD
    World Rank (Jul-30-2023)
    6,232
    Market Cap (Jul-30-2023)
    1.755 Billion USD
    World Rank (Dec-25-2022)
    10,850
    Market Cap (Dec-25-2022)
    0.644 Billion USD
    World Rank (Jan-07-2022)
    5,556
    Market Cap (Jan-07-2022)
    2.44 Billion USD
    Annual Revenue in USD
    35 Million USD
    Annual Net Income in USD
    -138 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Canada
    Company Profile
    Aurinia Pharmaceuticals is a Clinical Stage Biopharmaceutical company. The company developing in voclosporin, an investigational therapy for the treatment of lupus nephritis and other proteinuric diseases. The headquarters is in Canada.
    Company Website
    AURINIA PHARMACEUTICALS

  6. GH Research PLC

    World Rank (Aug-2026)
    6,291
    Market Cap (Aug-2026)
    2.022 Billion USD
    World Rank (Jan-05-2024)
    16,085
    Market Cap (Jan-05-2024)
    0.284 Billion USD
    World Rank (Jul-30-2023)
    10,432
    Market Cap (Jul-30-2023)
    0.732 Billion USD
    World Rank (Dec-25-2022)
    12,316
    Market Cap (Dec-25-2022)
    0.507 Billion USD
    World Rank (Jan-07-2022)
    9,593
    Market Cap (Jan-07-2022)
    0.97 Billion USD
    Headquarters Country
    Ireland
    Company Profile
    GH Research PLC is a clinical stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The headquarters is in Ireland.
    Company Website
    GH RESEARCH PLC

  7. Stoke Therapeutics

    World Rank (Aug-2026)
    6,298
    Market Cap (Aug-2026)
    2.018 Billion USD
    World Rank (Jan-05-2024)
    16,842
    Market Cap (Jan-05-2024)
    0.245 Billion USD
    World Rank (Jul-30-2023)
    16,233
    Market Cap (Jul-30-2023)
    0.280 Billion USD
    World Rank (Dec-25-2022)
    15,180
    Market Cap (Dec-25-2022)
    0.327 Billion USD
    World Rank (Jan-07-2022)
    11,113
    Market Cap (Jan-07-2022)
    0.74 Billion USD
    Annual Revenue in USD
    184 Million USD
    Annual Operating Income in USD
    -21 Million USD
    Annual Net Income in USD
    -7 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Stoke Therapeutics is a Biotechnology company. The company estimated annual revenue is currently 7.9 million USD per year and has 44 employees as on 2019. The headquarters is in USA.
    Company Website
    STOKE THERAPEUTICS

  8. Agios Pharmaceuticals

    World Rank (Aug-2026)
    6,312
    Market Cap (Aug-2026)
    2.004 Billion USD
    World Rank (Jan-05-2024)
    7,260
    Market Cap (Jan-05-2024)
    1.340 Billion USD
    World Rank (Jul-30-2023)
    6,950
    Market Cap (Jul-30-2023)
    1.477 Billion USD
    World Rank (Dec-25-2022)
    6,594
    Market Cap (Dec-25-2022)
    1.485 Billion USD
    World Rank (Jan-07-2022)
    6,755
    Market Cap (Jan-07-2022)
    1.77 Billion USD
    Annual Revenue in USD
    54 Million USD
    Annual Operating Income in USD
    -472 Million USD
    Annual Net Income in USD
    -413 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Bio-pharmaceutical company with headquarters is in Massachusetts, USA.
    Company Website
    AGIOS PHARMACEUTICALS INC

  9. Taysha Gene Therapies Inc.

    World Rank (Aug-2026)
    6,450
    Market Cap (Aug-2026)
    1.939 Billion USD
    World Rank (Jan-05-2024)
    15,206
    Market Cap (Jan-05-2024)
    0.329 Billion USD
    World Rank (Jul-30-2023)
    25,824
    Market Cap (Jul-30-2023)
    0.044 Billion USD
    World Rank (Dec-25-2022)
    20,293
    Market Cap (Dec-25-2022)
    0.130 Billion USD
    World Rank (Jan-07-2022)
    14,513
    Market Cap (Jan-07-2022)
    0.42 Billion USD
    Annual Revenue in USD
    10 Million USD
    Annual Operating Income in USD
    -110 Million USD
    Annual Net Income in USD
    -109 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Taysha Gene Therapies is a Biotechnology company focused on discovering, developing and commercializing gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) both in rare and large patient populations. It is having 10 employees as on 2019. The headquarters is in USA.
    Company Website
    TAYSHA GENE THERAPIES, INC.

  10. Sarepta Therapeutics

    World Rank (Aug-2026)
    6,508
    Market Cap (Aug-2026)
    1.912 Billion USD
    World Rank (Jan-05-2024)
    1,838
    Market Cap (Jan-05-2024)
    8.820 Billion USD
    World Rank (Jul-30-2023)
    1,662
    Market Cap (Jul-30-2023)
    10.109 Billion USD
    World Rank (Dec-25-2022)
    1,373
    Market Cap (Dec-25-2022)
    11.407 Billion USD
    World Rank (Jan-07-2022)
    2,400
    Market Cap (Jan-07-2022)
    7.45 Billion USD
    Annual Revenue in USD
    1,864 Million USD
    Annual Operating Income in USD
    -700 Million USD
    Annual Net Income in USD
    -713 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Biotechnology company with headquarters is in Massachusetts, USA.

    Company Website
    SAREPTA THERAPEUTICS INC
    Wikipedia
    Wikipedia

Share